Ameritas Investment Partners, Inc. Merck & Co., Inc. Transaction History

Ameritas Investment Partners, Inc.

$2.98 Billion
Q3 2024

A detailed history of Ameritas Investment Partners, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 55,688 shares of MRK stock, worth $5.52 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

55,688

Previous 58,964 5.56%

Holding current value

$5.52 Million

Previous $7.3 Million 13.37%

% of portfolio

0.21%

Previous 0.26%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$111.15 - $128.97 $364,127 - $422,505	-3,276 Reduced 5.56%	55,688 $6.32 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $631,008 - $677,697	-5,097 Reduced 7.96%	58,964 $7.3 Million
Q1 2024 May 13, 2024	SELL	$113.24 - $131.95 $129,433 - $150,818	-1,143 Reduced 1.75%	64,061 $8.45 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $287,216 - $312,560	-2,867 Reduced 4.21%	65,204 $7.11 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $532,663 - $591,543	-5,174 Reduced 7.06%	68,071 $7.01 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $420,320 - $458,130	-3,870 Reduced 5.02%	73,245 $8.45 Million
Q1 2023 May 10, 2023	SELL	$102.94 - $114.86 $16,985 - $18,951	-165 Reduced 0.21%	77,115 $8.2 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $241,246 - $309,311	-2,759 Reduced 3.45%	77,280 $8.57 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $1.52 Million - $1.71 Million	-17,990 Reduced 18.35%	80,039 $6.89 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $84,491 - $95,775	-1,012 Reduced 1.02%	98,029 $8.94 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $128,054 - $143,540	-1,742 Reduced 1.73%	99,041 $8.13 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $61,943 - $77,592	-857 Reduced 0.84%	100,783 $7.72 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $22,005 - $24,200	-307 Reduced 0.3%	101,640 $7.63 Million
Q2 2021 Aug 06, 2021	BUY	$70.31 - $77.77 $19,405 - $21,464	276 Added 0.27%	101,947 $7.93 Million
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $92,203 - $108,606	-1,339 Reduced 1.3%	101,671 $8.07 Million
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $210,860 - $234,011	-2,938 Reduced 2.77%	103,010 $8.43 Million
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $117,161 - $132,802	-1,601 Reduced 1.49%	105,948 $8.79 Million
Q2 2020 Aug 05, 2020	BUY	$70.42 - $80.13 $571,951 - $650,815	8,122 Added 8.17%	107,549 $8.32 Million
Q1 2020 May 13, 2020	SELL	$63.36 - $87.82 $88,513 - $122,684	-1,397 Reduced 1.39%	99,427 $7.65 Million
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $573,083 - $646,657	-7,387 Reduced 6.83%	100,824 $9.17 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $64,591 - $70,407	-849 Reduced 0.78%	108,211 $9.11 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $61,179 - $71,472	-876 Reduced 0.8%	109,060 $9.14 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $165,043 - $188,241	-2,372 Reduced 2.11%	109,936 $9.14 Million
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $237,995 - $276,190	3,648 Added 3.36%	112,308 $8.58 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $138,052 - $162,341	-2,393 Reduced 2.15%	108,660 $7.71 Million
Q2 2018 Aug 13, 2018	SELL	$50.83 - $59.72 $261,672 - $307,438	-5,148 Reduced 4.43%	111,053 $6.74 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $834,419 - $969,832	-16,374 Reduced 12.35%	116,201 $6.33 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $706,058 - $843,111	-13,678 Reduced 9.35%	132,575 $7.35 Million
Q3 2017 Nov 15, 2017	BUY	$58.67 - $63.13 $314,471 - $338,376	5,360 Added 3.8%	146,253 $9.35 Million
Q2 2017 Aug 15, 2017	BUY	N/A	140,893	140,893 $9.03 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Account

Ameritas Investment Partners, Inc. Merck & Co., Inc. Transaction History